6.33
Intensity Therapeutics Inc 주식(INTS)의 최신 뉴스
Forecast Cut: Can Intensity Therapeutics Inc ride the EV waveWeekly Profit Analysis & Technical Entry and Exit Alerts - baoquankhu1.vn
Intensity Therapeutics reports early trial data in breast cancer - Investing.com Nigeria
Intensity Therapeutics updates breast cancer trial, files to resume enrollment following study pause - MSN
Intensity Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Nigeria
Alliance Global Partners Sticks to Their Buy Rating for Intensity Therapeutics, Inc. (INTS) - The Globe and Mail
Intensity Therapeutics Inc (INTS) Stock Price, Quote, News & History - Benzinga
Intensity Therapeutics price target adjusted to $30 at Alliance Global - TipRanks
Intensity Therapeutics Updates Breast Cancer Trial, Files To Resume Enrollment Following Study Pause - Sahm
Intensity Therapeutics reports early trial data in breast cancer By Investing.com - Investing.com Australia
Intensity Therapeutics provides update on INVINCIBLE-4 Study - TipRanks
Ballard Reports Q4 2025 and Full Year Results - Weekly Voice
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study - ChartMill
INTS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS Stock Price, Quote & Chart | INTENSITY THERAPEUTICS INC (NASDAQ:INTS) - ChartMill
Bear Alert: Is Intensity Therapeutics Inc likely to announce a buyback2026 Intraday Action & Growth Focused Investment Plans - baoquankhu1.vn
Take Profit: Should I set a stop loss on Intensity Therapeutics Inc2026 Outlook & Safe Entry Point Identification - baoquankhu1.vn
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing - The Globe and Mail
Investment Review: Can Intensity Therapeutics Inc disrupt its industryQuarterly Earnings Report & Daily Oversold Bounce Ideas - baoquankhu1.vn
What's going on with Intensity Therapeutics stock Friday? - MSN
CT biotech firm regains Nasdaq compliance after carrying out reverse-stock split - Hartford Business Journal
Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement - marketscreener.com
Intensity Therapeutics Regains Nasdaq $1.00 Minimum Bid Price Compliance - TradingView
Intensity Therapeutics regains Nasdaq compliance - TipRanks
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement - PR Newswire
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
Intensity Therapeutics (INTS) posts updated preliminary financial highlights slide - Stock Titan
INTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Intensity Therapeutics Announces Reverse Stock Split - 富途牛牛
Swing Trade: Whats next for Intensity Therapeutics Inc stockPortfolio Return Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Retail Trends: Is Intensity Therapeutics Inc stock influenced by commodity pricesJuly 2025 Setups & Daily Profit Focused Screening - baoquankhu1.vn
INTS.O Technical Analysis & Stock Price Forecast - Intellectia AI
VTVT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS Should I Buy - Intellectia AI
INTS.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
INTS.O PE Ratio & Valuation, Is INTS.O Overvalued - Intellectia AI
Intensity Therapeutics (INTS) Price Target Increased by 2,399.98% to 74.38 - Nasdaq
Surprises Report: Whats next for Intensity Therapeutics Inc stock2025 Retail Activity & Free Community Consensus Stock Picks - baoquankhu1.vn
Aug Mood: Is Intensity Therapeutics Inc stock forming a cup and handleJuly 2025 Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Buy Signal: Should I set a stop loss on Intensity Therapeutics IncJuly 2025 Earnings & Accurate Buy Signal Alerts - baoquankhu1.vn
Sentiment Watch: Can MAAS deliver alphaWeekly Risk Summary & Weekly High Potential Alerts - baoquankhu1.vn
Intensity Therapeutics Inc Share Price USD0.0001 - Hargreaves Lansdown
How Intensity Therapeutics Inc. stock compares to market leadersJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - mfd.ru
Can Intensity Therapeutics Inc. stock beat market expectations this quarterWeekly Trade Analysis & Low Risk Investment Opportunities - mfd.ru
Is Intensity Therapeutics Inc.’s growth already priced inQuarterly Market Review & AI Enhanced Trading Signals - mfd.ru
Why did INTS stock plummet 25% today? - MSN
Why did INTS stock plummet 30% pre-market today? - MSN
CT biotech firm plans reverse stock split to regain Nasdaq compliance - Hartford Business Journal
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities - Weekly Voice
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Intellectia AI
Can Intensity Therapeutics Inc. disrupt its industryPortfolio Risk Report & Free Community Consensus Stock Picks - mfd.ru
Why Did INTS Stock Plummet 25% Today? - Stocktwits
Growth Review: Can Intensity Therapeutics Inc benefit from deglobalizationQuarterly Profit Review & Free Reliable Trade Execution Plans - baoquankhu1.vn
Intensity Therapeutics announces 1-for-25 reverse stock split By Investing.com - Investing.com Australia
자본화:
|
볼륨(24시간):